回盛生物: 2025年半年度报告摘要

| | | | | | | | | | 末增减 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 总资产（元） | | | | 2,967,997,412.77 | | | | | | | 3,014,682,865.02 | -1.55% | | | | | | | | | | 归属于上市公司股东的净资产（元） | | | | | | 2,058,589,798.43 | | | | | 1,457,576,824.02 | 41.23% | | | | | | | | | | 单位：股 | | | | | | | | | | | 报告期末普通股 | | | 报告期末表决权恢复的优先股 | | | | | | 持有 | | 特别表决权股份的股 | | | | | | | | | | | 股东总数 | 股东总数 | | | | | | | 东总数 | | | 前 10 | | | | 名股东持股情况（不含通过转融通出借股份） | | | | | | | | | | | | | | | | 质押、 | | 标记或冻结情况 | | ...